KalVista Pharmaceuticals Inc. Common Stock is a pharmaceutical company that specializes in the discovery, development, and commercialization of small molecule protease inhibitors. With a focus on diseases such as diabetic macular edema and hereditary angioedema, KalVista aims to provide innovative therapies that improve patients’ lives.
